Circulating tissue inhibitor of metalloproteinases 1 at coronavirus disease 2019 onset predicts severity status

HIGHLIGHTS

• who: Daniela Terracciano from the Santa Lucu00eda University General Hospital, Spain have published the research work: Circulating tissue inhibitor of metalloproteinases 1 at Coronavirus Disease 2019 onset predicts severity status, in the Journal: (JOURNAL)
• what: The authors investigated the potential role of PIIINP, HA and TIMP-1 as prognostic markers in COVID-19 patients.
• how: The study was conducted in compliance with the Declaration of Helsinki. The data showed that serum TIMP-1 in SARS-CoV-2 infected patients correlates with the WHO score and the CRP values but not with HRCT score . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.